1 Min Read
March 31 (Reuters) - Qiagen Nv
* Qiagen expands liquid biopsy pipeline with AR-V7 test in prostate cancer
* Qiagen NV - Qiagen has acquired an exclusive worldwide license from Johns Hopkins University Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.